Статті в журналах: "Heart failure"

1

Struthers, A. D. "HEART FAILURE: The diagnosis of heart failure." Heart 84, no. 3 (September 1, 2000): 334–38. http://dx.doi.org/10.1136/heart.84.3.334.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Westaby, S. "HEART FAILURE: Non-transplant surgery for heart failure." Heart 83, no. 5 (May 1, 2000): 603. http://dx.doi.org/10.1136/heart.83.5.603.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Pingitore, Alessandro, Francesca Mastorci, and Giorgio Iervasi. "Heart Failure and Stress Response." Biomed Data Journal 1, no. 3 (2015): 33–35. http://dx.doi.org/10.11610/bmdj.01300.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

McMurray, J. J. "HEART FAILURE: Epidemiology, aetiology, and prognosis of heart failure." Heart 83, no. 5 (May 1, 2000): 596–602. http://dx.doi.org/10.1136/heart.83.5.596.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Coats, A. J. S. "HEART FAILURE: What causes the symptoms of heart failure?" Heart 86, no. 5 (November 1, 2001): 574–78. http://dx.doi.org/10.1136/heart.86.5.574.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Eyubova, UA. "Modern Treatment Methods of Heart Failure." Clinical Cardiology and Cardiovascular Interventions 3, no. 9 (October 16, 2020): 01–02. http://dx.doi.org/10.31579/2641-0419/082.

Повний текст джерела

Анотація:

Modern methods of treatment of heart include, first of all, pathogenetic therapy and modern methods of treatment. Complete pathogenetic treatment has been achieved after the use of sacubitril / valsartan which is neprilysin inhibitor, whose use has been initiated in recent years. According to data provided in 2017, 26 million people worldwide suffer from heart failure.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Setianingsih, Mauludina Putri, and Yuni Dwi Hastuti. "Kelelahan pada Pasien Congestive Heart Failure." Holistic Nursing and Health Science 5, no. 2 (October 15, 2022): 178–87. http://dx.doi.org/10.14710/hnhs.5.2.2022.178-187.

Повний текст джерела

Анотація:

Introduction: Fatigue is a characteristic symptom and is often found in CHF patients and has a negative effect on daily activities, disease prognosis, and patient's quality of life. However, fatigue is a common symptom that is often overlooked and ignored. Limited study explored fatigue in CHF patients. The aim of this study was to explore fatigue in CHF patients. Methods: The research design is a descriptive survey. The total research sample is 85 respondents. Data were taken using a Multidimensional Assessment Fatigue (MAF) questionnaire with univariate data analysis in the form of a frequency distribution. Respondents involved in the study were patients aged >18 years who suffered from CHF based on a doctor's diagnosis and confirmed by medical records. Results: The majority of respondents are elderly with female gender, work as household workers, and heve income less than Rp1,500,000/month. Examination of vital signs performed on the majority of CHF patients showed normal temperature (36.5℃ - 37.5℃), pre-hypertensive blood pressure (120/80 - 139/89 mmHg), normal pulse (60-100x/min), and normal respiratory rate (12-20x/minute). Most patients have a CHF duration of 1–3 years, and are in grades 2 and 3 based on the New York Association (NYHA) classification. The results of this study were 65.9% of CHF patients experienced moderate fatigue, 17.6% severe fatigue, and 16.5% mild fatigue. Conclusion: Health services can consider efforts to improve the quality of nursing services in overcoming or minimizing fatigue experienced by CHF patients. These efforts can be a therapy, evidence-based health education, or fatigue monitoring for preventing a worsening of disease prognosis and improving the patient's quality of life. Keywords: CHF, Fatigue, Multidimensional Assesment Fatigue.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Setianingsih, Mauludina Putri, and Yuni Dwi Hastuti. "Kelelahan pada Pasien Congestive Heart Failure." Holistic Nursing and Health Science 5, no. 2 (October 15, 2022): 178–87. http://dx.doi.org/10.14710/hnhs.5.2.2022.34-43.

Повний текст джерела

Анотація:

Introduction: Fatigue is a characteristic symptom and is often found in CHF patients and has a negative effect on daily activities, disease prognosis, and patient's quality of life. However, fatigue is a common symptom that is often overlooked and ignored. Limited study explored fatigue in CHF patients. The aim of this study was to explore fatigue in CHF patients. Methods: The research design is a descriptive survey. The total research sample is 85 respondents. Data were taken using a Multidimensional Assessment Fatigue (MAF) questionnaire with univariate data analysis in the form of a frequency distribution. Respondents involved in the study were patients aged >18 years who suffered from CHF based on a doctor's diagnosis and confirmed by medical records. Results: The majority of respondents are elderly with female gender, work as household workers, and heve income less than Rp1,500,000/month. Examination of vital signs performed on the majority of CHF patients showed normal temperature (36.5℃ - 37.5℃), pre-hypertensive blood pressure (120/80 - 139/89 mmHg), normal pulse (60-100x/min), and normal respiratory rate (12-20x/minute). Most patients have a CHF duration of 1–3 years, and are in grades 2 and 3 based on the New York Association (NYHA) classification. The results of this study were 65.9% of CHF patients experienced moderate fatigue, 17.6% severe fatigue, and 16.5% mild fatigue. Conclusion: Health services can consider efforts to improve the quality of nursing services in overcoming or minimizing fatigue experienced by CHF patients. These efforts can be a therapy, evidence-based health education, or fatigue monitoring for preventing a worsening of disease prognosis and improving the patient's quality of life. Keywords: CHF, Fatigue, Multidimensional Assesment Fatigue.

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Kishanrao, Suresh. "Congestive Heart Failure in Indian Elders." Clinical Cardiovascular Research 2, no. 1 (March 1, 2023): 01–04. http://dx.doi.org/10.58489/2836-5917/006.

Повний текст джерела

Анотація:

Congestive Heart Failure (CHF) is a common complex clinical syndrome that underlines the inability of the heart to perform its circulatory function with the desired efficiency due to structural and/or functional alterations. There is paucity of good and reliable data in India and many developing countries on heart failure. The management of heart failurehas evolved over the years with the advent of new drugs and devices.But there is a need to uneartha true and meaningful nationaldata on the risk factors,available treatment options,and challenges in management that could be addressed to take advantage of the recent advances. CHF is a disease of the “elderly,” frequently occurs in the setting of normal ejection fraction, and has a poor prognosis, regardless of the level of systolic function. The highest prevalence of CHF is reported among Indigenous Australian population (5.3%), Germany (4%) and Canada 3.6%, Turkey 2.9%, and USA 2.6% as compared to only 0.3% in Indian population. Overall, more than 5 persons aged 60 to 69 and 10 persons per 1,000 population after 65 years of age suffer from CHF. The incidence of CHF is equally frequent in men and women globally, but it is more amongelderly women in India comparedto elderly men. The burden of heart failure is increasing at an alarming rate worldwide as well as in India. CHF not only increases the risk of mortality, morbidity and worsens the patient’s quality of life, but also puts a huge burden on the overall healthcare system. We need to acknowledge the fact that diagnostic and therapeutic methods available are also underused in the community. This review article is the result of witnessing the heart failure in 4 individuals in January 2023. Their symptomsand signs included Shortness of breath with routine activity like walking or household chores, fatigue, and weakness, Pedal oedema, rapid or irregular heartbeat, fluctuating Blood Pressure and Blood sugar levels, reduced ability to exercise and vomiting and aspirational pneumonia. The exponential rise in the incidence of uncontrolled hypertension and DM over the last couple of years has shaped the trajectory of HF development seen today. The key risk factors and causes of HF in our cases included hypertension (HT), diabetes mellitus (DM); chronic kidney disease (CKD). With the bestpossible management practices in cities likeBengaluru and Mysuru in Karnataka we could save only two of the 4 cases,both first-time hospitalized patients. Materials & Methods: The third week of January2023 (17-25 January), the author had a misfortune being a witnessfor 3 women and one man between 64-85 years of age’s hospitalized for CHF with an outcome of 50% of them succumbing to CHF. This manuscript is a review of available information on the websites of World Heart Federation 2020, WHO, Global burden of disease 2019 report, ICC - National Heart Failure Registry, Reports of the Best Charities that fight Heart Diseases in 2023 including American Heart Association, The Children’s Heart Foundation, British Heart Foundation, Mended Hearts, Women Heart, Needy heart Foundation Bangalore and published papers in Indiaas evidences.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Maggioni, A. P. "HEART FAILURE: Treatment strategies for heart failure: beta blockers and antiarrhythmics." Heart 85, no. 1 (January 1, 2001): 97–103. http://dx.doi.org/10.1136/heart.85.1.97.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Bhatti, Muhammad Ijaz, Majid Kaleem, and Asif Hanif. "HEART FAILURE." Professional Medical Journal 25, no. 06 (June 9, 2018): 865–69. http://dx.doi.org/10.29309/tpmj/18.4489.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Shah, Dr Reena, Dr Sunita J. Solanki, Dr Prakash patel, and Dr Neeraj Singh Dr.Neeraj Singh. "Study of Incidence of Heart Failure with Reduced Ejection Fraction and Heart Failure with Normal Ejection Fraction." International Journal of Scientific Research 2, no. 10 (June 1, 2012): 1–2. http://dx.doi.org/10.15373/22778179/oct2013/104.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Giles, Thomas D. "Hypertension and Heart Failure Sine Heart Failure." Journal of Clinical Hypertension 5, no. 4 (July 2003): 280–81. http://dx.doi.org/10.1111/j.1524-6175.2003.02476.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Wenger, Nanette K. "Women, Heart Failure, and Heart Failure Therapies." Circulation 105, no. 13 (April 2, 2002): 1526–28. http://dx.doi.org/10.1161/01.cir.0000014121.94868.81.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Aydin, Seda Guzel, Turgay Kaya, and Hasan Guler. "Heart Rate Variability (HRV) Based Feature Extraction for Congestive Heart Failure." International Journal of Computer and Electrical Engineering 8, no. 4 (2016): 272–79. http://dx.doi.org/10.17706/ijcee.2016.8.4.272-279.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

McMurray, J. J. V. "HEART FAILURE: Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction." Heart 86, no. 1 (July 1, 2001): 97–103. http://dx.doi.org/10.1136/heart.86.1.97.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Petrie, M. C. ""Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction?" Heart 87, no. 1 (January 1, 2002): 29–31. http://dx.doi.org/10.1136/heart.87.1.29.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Benbow, Denise A. "Heart failure." Nursing 39 (2009): 5–7. http://dx.doi.org/10.1097/01.nurse.0000359676.43893.e1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Richardson, Lendell. "Heart failure." Journal of the American Academy of Physician Assistants 34, no. 6 (June 2021): 48–50. http://dx.doi.org/10.1097/01.jaa.0000743008.36429.8b.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Rockwell, Jean M. "Heart Failure." American Journal of Nursing 99, no. 10 (October 1999): 24BB. http://dx.doi.org/10.2307/3521906.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Trainor, Róisín, Eamon P. McCarron, Shiva Sreenivasan, and Monica Monaghan. "Heart Failure." Annals of Internal Medicine 169, no. 10 (November 20, 2018): 737. http://dx.doi.org/10.7326/l18-0463.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Wu, Audrey. "Heart Failure." Annals of Internal Medicine 169, no. 10 (November 20, 2018): 738. http://dx.doi.org/10.7326/l18-0464.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Clark, Andrew. "Heart failure." Srce i krvni sudovi 31, no. 4 (2012): 48–55. http://dx.doi.org/10.5937/siks1201048c.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Why, Howard. "Heart failure." Elderly Care 4, no. 2 (April 1992): 18–20. http://dx.doi.org/10.7748/eldc.4.2.18.s30.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Laine, Christine. "Heart Failure." Annals of Internal Medicine 147, no. 11 (December 4, 2007): ITC12. http://dx.doi.org/10.7326/0003-4819-147-11-200712040-01012.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Basile, Jan N. "Heart failure." Postgraduate Medicine 113, no. 3 (March 2003): 29–30. http://dx.doi.org/10.3810/pgm.2003.03.1386.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Snider, Louise. "Heart failure." Nursing Standard 20, no. 4 (October 5, 2005): 67–68. http://dx.doi.org/10.7748/ns.20.4.67.s57.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Tsao, Lana, and C. Michael Gibson. "Heart Failure." Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3, no. 4 (December 2004): 194–204. http://dx.doi.org/10.1097/01.hpc.0000146867.90558.ca.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Turner, Barbara. "Heart Failure." Annals of Internal Medicine 152, no. 11 (June 1, 2010): ITC6. http://dx.doi.org/10.7326/0003-4819-152-11-201006010-01006.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Wu, Audrey. "Heart Failure." Annals of Internal Medicine 168, no. 11 (June 5, 2018): ITC81—ITC96. http://dx.doi.org/10.7326/aitc201806050.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Ilyas, Aneeqa, Muhammad Hassan Zafar, and Sana Amin. "HEART FAILURE." Professional Medical Journal 25, no. 02 (February 3, 2018): 282–86. http://dx.doi.org/10.29309/tpmj/18.4194.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Bhatti, Muhammad Ijaz, Majid Kaleem, and Asif Hanif. "HEART FAILURE." Professional Medical Journal 25, no. 06 (June 10, 2018): 865–69. http://dx.doi.org/10.29309/tpmj/2018.25.06.272.

Повний текст джерела

Анотація:

Objectives: To identify factors which cause deterioration with worsening ofsymptoms in previously stable heart failure patients. Study design: Descriptive case seriesSetting: Gulab Devi Chest Hospital, Lahore. Duration: 01-04-2017 to 30-09-2017. Patientsand Methods: The study was done on 100 patients diagnosed with LV systolic dysfunctionor cardiomyopathy with LVEF<40%. Patients were examined regarding clinical signs ofdecompensation and detailed history was taken to probe the cause of decompensation. Allinformation was noted down on a pre-defined questionnaire. Mean ± S.D was applied forquantitative data like age and LVEF. Frequency (%) was used for qualitative data like gender.Results: Non compliance to drugs was the most common cause of decompensation (56%),amongst them 73.21% cases were noncompliant due to poor awareness about the importanceof continuing use of medicines. Infection was the second common precipitating factor(51%), where chest infection was the most common cause in 74.51% cases. Other causes ofdecompensation were ischaemia (28%), renal impairment (36%), and arrhythmias (23%) whilemore than one precipitating factors were found in 41% of cases. Conclusion: Multiple factorscan trigger deterioration in patients with previously stable heart failure. Recognition of thesefactors is important for good long term outcome in these patients.

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Ilyas, Aneeqa, Muhammad Hassan Zafar, and Sana Amin. "HEART FAILURE." Professional Medical Journal 25, no. 02 (February 10, 2018): 282–86. http://dx.doi.org/10.29309/tpmj/2018.25.02.457.

Повний текст джерела

Анотація:

Objectives: To observe the function of left ventricular contractile and its pairingwith failure preserved ejection fraction. Study Design: Observational longitudinal study.Setting: Punjab institute of Cardiology. Period: Jan 2017 to June 2017. Methods: Four Hundredtwenty one Heart failure patients (mean age 51 ± 7 years, 56% females, left ventricular ejectionfraction 55±5%) undergo Left ventricular investigation through echocardiography and left heartcatheterization of 191 patients. Through tricuspid annular plane systolic excursion (TAPSE),Patients were sorting out and data collect. Mean TAPSE score were 15.03±4.06 cm without anygender differences. Body surface presents strong relation with TAPSE values (r=0.74). Manydifferent pattern consistently found within same patients leading to heart failure, but patientswith HFpEFin which each component is operative behave differently. Results: Transformationof different evidences in clinical practice needs proper level of proofs regarding evidences. Outof four hundred twenty one heart failure patients, patients with prolonged heart failure symptomsand high rate of ejection fraction due to adaptive changes by the human body, whereas patientswith aggressive mode of work have high mortality ratio. Out of all physiological derangementswere strongly link with the TAPSE. Different biomarker-based strategies are much required toimplement for excellent patient outcome in heart diseases. Conclusion: Using most commonclinical features, we listed four major features with mark differences acts in remodeling andmaintain in heart failure. Patients with decreases ejection fraction have more advanced heartfailure. Therapeutic treatment specifically targeting main components of heart failure havebetter pathophysiological changes in less time. HFpEF patients are more chances to developadaptive cardiac changes.

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Rehman Mir, Naeem-ur, Naeem Asghar, and Shaukat Javed. "HEART FAILURE;." Professional Medical Journal 24, no. 06 (June 5, 2017): 912–18. http://dx.doi.org/10.29309/tpmj/2017.24.06.1198.

Повний текст джерела

Анотація:

Introduction: Atrial fibrillation (AF) and wider QRS duration have long beenidentified to worsen heart failure and LV dysfunction and increase cardiovascular morbidityand mortality. Therefore, it is necessary to identify those patients of heart failure who are atgreater risk for cardiovascular morbidity and mortality so that such subjects may be focusedfor preventive strategies. An association exists between QRS duration and AF with greaterincidences of cardiovascular events in patients of heart failure with LV systolic dysfunction.Study Design: Cross sectional survey. Setting: Department of Cardiology, Punjab Institute ofCardiology Lahore. Period: 16-02-2015 to 15-08-2015. Material and Methods: The objectiveof study was to determine the Frequency of QRS Duration groups and Atrial Fibrillation inPatients with Left Ventricular Dysfunction. Sample size of 400 cases was calculated with 95%confidence level, 4% margin of error and taking expected percentage of atrial fibrillation innarrow QRS group i.e. 20.9% (least among all) in patients with left ventricular dysfunction.Sampling technique was non-probability, purposive sampling. Result: The study populationconsisted of male (72.3%) and female (27.7%). Mean LA diameter was 40.3±6.08 mm andmean LV ejection fraction 31.8±6.6 % in the study population. Ischemic heart disease wasthe most common cause of LV dysfunction (88.3%) followed by non-ischemic cardiomyopathy(8.75%) and non-Ischemic valvular heart disease (3.5%). The frequency of Narrow QRSd (<120ms) was 62%, Intermediate QRSd (120-150 ms) was 26.5% and Wide QRSd (>150 ms) was11.5%. The frequency of atrial fibrillation in study population was 15.75%. The frequency of atrialfibrillation was highest in Wide QRSd group (>150 ms) i.e. (60.9%), followed by IntermediateQRSd group (120-150 ms) i.e. (18.9%) and narrow QRSd group (<120 ms) i.e. (6.04%). Patientwith atrial fibrillation were more likely to have poor ejection fraction (P<0.0023) and wider QRSduration (P<0.0001). Frequency of atrial fibrillation was highest in Valvular Cardiomyopathy(non-ischemic valvular heart disease) patients (42.8%) as compared to coronary artery diseasegroup (15.3%) and non-ischemic cardimyopathy group (9.4%). Conclusion: In patients of heartfailure with reduced ejection fraction (HFrEF), the frequency of atrial fibrillation increases asQRS duration widens. This group of patients must be focused for AF preventive strategies.

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Scott, W. Guy, and Helen M. Scott. "Heart Failure." PharmacoEconomics 9, no. 2 (February 1996): 156–67. http://dx.doi.org/10.2165/00019053-199609020-00007.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Uemura, Shiro, and Yoshihiko Saito. "Heart failure." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 47, no. 5 (2010): 403–5. http://dx.doi.org/10.3143/geriatrics.47.403.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Giamouzis, Gregory, Filippos Triposkiadis, Javed Butler, Dirk Westermann, and George Giannakoulas. "Heart Failure." Cardiology Research and Practice 2011 (2011): 1–2. http://dx.doi.org/10.4061/2011/159608.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Jessup, Mariell, and Susan Brozena. "Heart Failure." New England Journal of Medicine 348, no. 20 (May 15, 2003): 2007–18. http://dx.doi.org/10.1056/nejmra021498.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Magner, J. J., and D. Royston. "Heart failure." British Journal of Anaesthesia 93, no. 1 (July 2004): 74–85. http://dx.doi.org/10.1093/bja/aeh167.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Arsenos, P., K. A. Gatzoulis, T. Gialernios, P. Dilaveris, S. Archontakis, D. Tsiachris, D. Mytas, et al. "Heart Failure." Europace 13, Supplement 1 (January 31, 2011): i18—i19. http://dx.doi.org/10.1093/europace/euq476.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Subramaniam, Kathirvel. "Heart Failure." International Anesthesiology Clinics 50, no. 3 (2012): x—xi. http://dx.doi.org/10.1097/aia.0b013e31825bf53d.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Harris, Keara R., and Mareike K. Thompson. "Heart Failure." InnovAiT: Education and inspiration for general practice 5, no. 11 (October 22, 2012): 687–95. http://dx.doi.org/10.1093/innovait/ins181.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Henderson, A. H. "Heart failure." Current Opinion in Cardiology 1, no. 3 (May 1986): 334–39. http://dx.doi.org/10.1097/00001573-198605000-00002.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Reigle, Juanita. "Heart Failure." AACN Clinical Issues: Advanced Practice in Acute and Critical Care 9, no. 2 (May 1998): 155–56. http://dx.doi.org/10.1097/00044067-199805000-00001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Spacie, Robin, James M. Duffell, and Megan Jones. "Heart failure." InnovAiT: Education and inspiration for general practice 12, no. 5 (March 25, 2019): 243–51. http://dx.doi.org/10.1177/1755738019829789.

Повний текст джерела

Анотація:

Heart failure is a progressive condition that is increasing in prevalence. Clinical findings, together with natriuretic peptide measurement and echocardiography, underpin diagnosis. Drugs can improve the prognosis (ACE-inhibitor, beta blockers) and ameliorate symptoms (diuretics). Non-pharmacological treatment includes exercise therapy, smoking cessation and nutritional care. Heart failure has a poor prognosis and early palliative input is recommended.

Стилі APA, Harvard, Vancouver, ISO та ін.

46

POPE, BARBARA B. "Heart failure." Nursing 32, no. 8 (August 2002): 50–51. http://dx.doi.org/10.1097/00152193-200208000-00047.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

AYERS, DENISE M. McENROE. "Heart failure." Nursing 34, no. 11 (November 2004): 46–47. http://dx.doi.org/10.1097/00152193-200411000-00042.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

MARBÁN, EDUARDO. "Heart Failure:." Journal of Cardiovascular Electrophysiology 10, no. 10 (October 1999): 1425–28. http://dx.doi.org/10.1111/j.1540-8167.1999.tb00199.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Lekan-Rutledge, Deborah. "HEART FAILURE." AJN, American Journal of Nursing 104, no. 5 (May 2004): 15. http://dx.doi.org/10.1097/00000446-200405000-00005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Moser, Debra K. "Heart Failure." Western Journal of Nursing Research 39, no. 4 (January 8, 2017): 451–54. http://dx.doi.org/10.1177/0193945916687241.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Статті в журналах з теми "Heart failure"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями